These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 32265752)
1. Sensory Processing Difficulties in Youths With Disruptive Mood Dysregulation Disorder. Benarous X; Bury V; Lahaye H; Desrosiers L; Cohen D; Guilé JM Front Psychiatry; 2020; 11():164. PubMed ID: 32265752 [TBL] [Abstract][Full Text] [Related]
2. Missing the forest for the trees? A high rate of motor and language impairments in Disruptive Mood Dysregulation Disorder in a chart review of inpatient adolescents. Benarous X; Iancu C; Guilé JM; Consoli A; Cohen D Eur Child Adolesc Psychiatry; 2021 Oct; 30(10):1579-1590. PubMed ID: 32918099 [TBL] [Abstract][Full Text] [Related]
3. Are youths with disruptive mood dysregulation disorder different from youths with major depressive disorder or persistent depressive disorder? Benarous X; Renaud J; Breton JJ; Cohen D; Labelle R; Guilé JM J Affect Disord; 2020 Mar; 265():207-215. PubMed ID: 32090743 [TBL] [Abstract][Full Text] [Related]
4. Associations Between Chronic Irritability and Sensory Processing Difficulties in Children and Adolescents. Harima Y; Miyawaki D; Goto A; Hirai K; Sakamoto S; Hama H; Kadono S; Nishiura S; Inoue K Front Psychiatry; 2022; 13():860278. PubMed ID: 35573381 [TBL] [Abstract][Full Text] [Related]
5. Disruptive mood dysregulation disorder at the age of 6 years and clinical and functional outcomes 3 years later. Dougherty LR; Smith VC; Bufferd SJ; Kessel EM; Carlson GA; Klein DN Psychol Med; 2016 Apr; 46(5):1103-14. PubMed ID: 26786551 [TBL] [Abstract][Full Text] [Related]
6. Toward a Developmental Nosology for Disruptive Mood Dysregulation Disorder in Early Childhood. Wiggins JL; Briggs-Gowan MJ; Brotman MA; Leibenluft E; Wakschlag LS J Am Acad Child Adolesc Psychiatry; 2021 Mar; 60(3):388-397. PubMed ID: 32599006 [TBL] [Abstract][Full Text] [Related]
7. Disruptive Mood Dysregulation Disorder in a Community Mental Health Clinic: Prevalence, Comorbidity and Correlates. Freeman AJ; Youngstrom EA; Youngstrom JK; Findling RL J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):123-30. PubMed ID: 26745325 [TBL] [Abstract][Full Text] [Related]
9. Characteristic Similarities of Irritability Between Autism and Disruptive Mood Dysregulation Disorder. Pan PY; Yeh CB J Child Adolesc Psychopharmacol; 2023 Dec; 33(10):428-432. PubMed ID: 37883643 [No Abstract] [Full Text] [Related]
10. An exploratory clinical study of disruptive mood dysregulation disorder in children and adolescents from India. Tiwari R; Agarwal V; Arya A; Gupta PK; Mahour P Asian J Psychiatr; 2016 Jun; 21():37-40. PubMed ID: 27208455 [TBL] [Abstract][Full Text] [Related]
12. Predictors of Later Psychopathology in Young Children with Disruptive Mood Dysregulation Disorder. Dougherty LR; Barrios CS; Carlson GA; Klein DN J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):396-402. PubMed ID: 28398817 [TBL] [Abstract][Full Text] [Related]
13. Psychiatric comorbidity and social adjustment difficulties in children with disruptive mood dysregulation disorder: A national epidemiological study. Lin YJ; Tseng WL; Gau SS J Affect Disord; 2021 Feb; 281():485-492. PubMed ID: 33383391 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Trends and Prescription Patterns in Disruptive Mood Dysregulation Disorder and Bipolar Disorder. Findling RL; Zhou X; George P; Chappell PB J Am Acad Child Adolesc Psychiatry; 2022 Mar; 61(3):434-445. PubMed ID: 34091008 [TBL] [Abstract][Full Text] [Related]
15. Persistence of disruptive mood dysregulation disorder in children with attention-deficit/hyperactivity disorder. Mulraney M; Silk TJ; Gulenc A; Efron D; Hazell P; Sciberras E J Affect Disord; 2021 Jan; 278():502-505. PubMed ID: 33017677 [TBL] [Abstract][Full Text] [Related]
16. DSM-5 disruptive mood dysregulation disorder: correlates and predictors in young children. Dougherty LR; Smith VC; Bufferd SJ; Carlson GA; Stringaris A; Leibenluft E; Klein DN Psychol Med; 2014 Aug; 44(11):2339-50. PubMed ID: 24443797 [TBL] [Abstract][Full Text] [Related]
17. An expert opinion on the pharmacological interventions for Disruptive Mood Dysregulation Disorder (DMDD). Orsolini L; Longo G; Cicolini A; Volpe U Expert Opin Pharmacother; 2024; 25(1):67-78. PubMed ID: 38186365 [TBL] [Abstract][Full Text] [Related]
18. Development and Initial Validation of the Disruptive Mood Dysregulation Disorder Questionnaire Among Adolescents From Clinic Settings. Boudjerida A; Labelle R; Bergeron L; Berthiaume C; Guilé JM; Breton JJ Front Psychiatry; 2022; 13():617991. PubMed ID: 35250652 [TBL] [Abstract][Full Text] [Related]
19. Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study. Pan PY; Fu AT; Yeh CB J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):682-689. PubMed ID: 30148656 [TBL] [Abstract][Full Text] [Related]
20. Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder. Winters DE; Fukui S; Leibenluft E; Hulvershorn LA J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):298-305. PubMed ID: 29708762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]